By keeping our patients’ and customers’ safety and well-being at the core of everything we do.
By focusing our unique combination of stem cell technology and plastic surgery into new treatment solutions.
By partnering with leading plastic surgeons, hospitals & healthcare professionals, and academia.
Stemform has spent years modifying and perfecting a commercially viable stem cell-enriched fat grafting solution for cosmetic treatments.
Our founder, Dr. Stig-Frederik Trojahn Kølle, acknowledged the benefits of using a patient’s own fat for cosmetic treatments (e.g., breast augmentation, facial filling, wrinkle treatment and skin rejuvenation), as this material will always be biocompatible, natural appearing, non-immunogenic and versatile.
However, the transplanted fat graft is unpredictable and often has low survival. Thus, several procedures are needed to achieve an acceptable cosmetic outcome. Moreover, such transplants may not result in patient satisfaction and may not be a viable option for all people (e.g., thin people).
Inspired by scientific findings, Stemform was established in 2014 in Copenhagen, Denmark to begin modifying and perfecting a commercially viable stem cell-enriched fat grafting solution for various cosmetic treatments.
After targeted developmental work, we are now able to offer what we believe is a safe, natural, reliable, effective, and permanent fat grafting solution tailored to and around the individual patient. This treatment solution provides huge advantages over current artificial, synthetic, temporary, and unreliable cosmetic solutions.
We are proud to be pioneers of this new treatment regimen in modern plastic surgery and are committed to serving our patients and customers at the highest standards to always ensure satisfaction across the board while working hard to make the innovative treatments accessible to as many people as possible both geographically and economically.
Stig-Frederik Trojahn Kølle
Stig-Frederik has been spearheading the R&D and clinical trial programs at Stemform since founding the company. Furthermore, he oversees the company’s stem cell production activities.
Stig-Frederik is a certified plastic surgeon from Copenhagen University Hospital, Rigshospitalet. He worked as an Associate Professor of Plastic Surgery at the University during his employment at Rigshospitalet and Herlev hospitals. He holds a PhD and has worked in Plastic and Reconstructive Surgery and Stem Cell Technology since 2009.
Peter has been responsible for all the company’s administrative, financial, and operational activities since co-founding the company.
Prior to joining Stemform, Peter worked for Royal Dutch Shell for 10 years in various roles spanning business transformation, business development, marketing, sales, and trading.
Peter earned an M.Sc. in Innovation and Business Development from Copenhagen Business School in 2005.
Head of Tissue Establishment and Regulatory Affairs
Anne has been responsible for all Stemform’s tissue establishment activities and regulatory affairs since co-founding the company.
Anne has worked with cell-based therapies for more than ten years and has headed a tissue establishment and cell therapy facility at a public hospital since 2010.
Anne holds an MD and PhD, and is a specialist in clinical immunology.
Board of directors
Stig-Frederik Trojahn Kølle
Anders Christian Wolf Kølle